Green Planet Bio Engineering GPLB

OTC GPLB
$0.01 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Green Planet Bio Engineering (GPLB) stock price is $0.01, unchanged on the day, as of Nov 9, 2026. It has a market cap of $200.06K, and is classified in the Investment Banking industry (Financial Services sector).

Key Stats
Market Cap200,064.02
P/E-4.79
FCF (Yr)-36,544.00
ROA (Yr)–
EV to EBIT-4.81
Net Income (Yr)-35,842.00
Enterprise Value200,064.02
Add ratio to table…

About

Green Planet Bioengineering Co., Ltd. operates as a public reorganized shell corporation with the purpose to acquire or merge with an existing business operation. The company does not engage in ongoing commercial activities or generate revenue from products or services. Its primary function is to seek and complete a business combination with a private operating company. Green Planet Bioengineering Co., Ltd. does not generate revenue from the sale of goods or services. As a…

Read more ↓
Sector: Financial Services Sector rationale The company is a public shell corporation whose sole purpose is to acquire or merge with another business. This activity—functioning as a vehicle for mergers and acquisitions—falls under the financial activities of specialty finance or investment-related structures within Financial Services, as it has no operational products or services in any other sector. Industry: Investment Banking Investment Banking Primary The company operates as a public shell corporation whose sole purpose is to acquire or merge with an existing business operation. This activity of seeking and completing a business combination is a core function of investment banking and corporate finance advisory, as it involves the restructuring and capital raising necessary for a merger. Classified using BQ-MICS CIK: 0001392449
Peer percentiles

How Green Planet Bio Engineering ranks

Ranked against the 155 companies in Capital Markets58 metrics · as of Nov 11, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last
  • P/ENegative earnings −4.79xMedian 44.6x 11th
  • P/FCFNegative free cash flow −3.78xMedian 15.2x 15th
  • P/Operating cash flowNegative operating cash flow −3.78xMedian 14.1x 13th
  • P/S —Median 3.14x No data —
  • P/BNegative shareholder equity −0.39xMedian 3.29x Not meaningful —
  • P/Tangible bookNegative tangible equity −0.39xMedian 4.60x Not meaningful —
  • EV/EBITDA —Median 11.9x No data —
  • EV/EBITNegative EBIT −4.81xMedian 17.3x 8th
  • EV/Revenue —Median 3.81x No data —
  • EV/FCFNegative free cash flow −3.78xMedian 16.5x 10th
  • EV/Operating cash flowNegative operating cash flow −3.78xMedian 14.7x 8th
  • PEG (3Y EPS CAGR)Negative earnings 2.98Median 0.55 Not meaningful —
Peer group

Peer Comparison

Companies in the Investment Banking
View all peers
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 CME Cme Group Inc. 110.48 Bn25.0715.853.43 Bn
2 BNY Bank of New York Mellon Corp 101.69 Bn16.324.6341.16 Bn
3 ICE Intercontinental Exchange, Inc. 98.41 Bn23.777.0023.30 Bn
4 HOOD Robinhood Markets, Inc. 73.28 Bn36.8114.422.66 Bn
5 NDAQ Nasdaq, Inc. 61.44 Bn29.516.728.74 Bn
6 STT State Street Corp 46.84 Bn13.653.0226.04 Bn
7 CBOE Cboe Global Markets, Inc. 38.04 Bn25.827.211.44 Bn
8 GPLB Green Planet Bio Engineering Co. Ltd. 0.00 Bn-4.79--